We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques...
Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers...
Position de trésorerie de 10,2 millions d’euros au 31 mars 2024, intégrant l’opération de financement réalisée en mars 20241, comprenant : Une levée de fonds pour un montant de 2 millions...
Cash position of €10.2 million as of March 31, 2024, includes proceeds from the March 2024 financing1, featuring: €2 million invested by three members of management and Vester Finance, the...
Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC) (Paris:ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions...
Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC) (Paris:ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions...
Cash of €13.0m (million) as of December 31, 2023 (€17.4m as of December 31, 2022), including: The signing of an exclusivity agreement with Sanofi on M1Pram and payment of €10m The July 2023 €10m...
Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers...
Regulatory News: Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers (« AMF »). ADOCIA SA...
A €2 million fundraising for the benefit of: Gérard Soula, President, Olivier Soula, Chief Executive Officer, co-founders, and a member of the Management, for a total amount of €1 million Vester...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | -4.15 | -59.2857142857 | 7 | 10.18 | 2.5 | 57067 | 3.31444126 | CS |
26 | -8.7 | -75.3246753247 | 11.55 | 11.96 | 2.5 | 18296 | 7.24431933 | CS |
52 | -8.14 | -74.0673339399 | 10.99 | 11.96 | 2.5 | 10299 | 8.60395653 | CS |
156 | -7.15 | -71.5 | 10 | 11.96 | 2.5 | 13091 | 9.8766598 | CS |
260 | -7.12 | -71.4142427282 | 9.97 | 11.96 | 2.5 | 19932 | 9.9890508 | CS |
Symbol | Price | Vol. |
---|---|---|
HLTHCue Health Inc | $ 0.0724 (32.12%) | 583.02M |
FFIEFaraday Future Intelligent Electric Inc | $ 0.563903 (26.95%) | 582.94M |
GWAVGreenwave Technology Solutions Inc | $ 0.04175 (-15.49%) | 423.93M |
CRKNCrown Electrokinetics Corporation | $ 0.113298 (28.75%) | 277.58M |
VERBVerb Technology Company Inc | $ 0.1572 (-2.48%) | 166.17M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions